Regulatory support for the development of a stem cell therapy and device for the treatment of Parkinson’s Disease
Boyds provided regulatory support to an academic institution client with an exciting proposal for a first-in-human stem cell therapy trial involving a medical device for the treatment of Parkinson’s Disease.
Combined gene therapy expertise supports US biotech
The client was an early-stage start-up in the pre-clinical stage of developing a suite of gene therapy products for a cardiovascular indication.
Progress of cell and gene therapies
Huge leaps forward in the development of cell and gene therapies have been made over the past few years, progressing the development of new treatments for diseases that were considered untreatable only a decade ago. In recent weeks there has been a significant flow of positive news about different types of advanced therapies. It was […]